James K. Hogan

678 total citations
10 papers, 256 citations indexed

About

James K. Hogan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, James K. Hogan has authored 10 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in James K. Hogan's work include Cytokine Signaling Pathways and Interactions (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Protein Structure and Dynamics (2 papers). James K. Hogan is often cited by papers focused on Cytokine Signaling Pathways and Interactions (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Protein Structure and Dynamics (2 papers). James K. Hogan collaborates with scholars based in United States and Canada. James K. Hogan's co-authors include Yunyi Wei, Kuenhi Tsai, Melissa Swope Willis, Prakash Prabhakar, Ted Fox, Marvin Gold, Luke S. Oh, Sudipta Mahajan, Bailey W. Miller and J. Andrew McCammon and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

James K. Hogan

9 papers receiving 245 citations

Peers

James K. Hogan

ONCOL

BIOTE

GENET

Emilia Rappocciolo Italy

F. Di Pisa Italy

Charlotte A. Bartlett United States

Jonathan L. Doty United States

Linghao Niu United States

Kristine E. Frank United States

Bolong Cao United States

Wanren Li Austria

Yves Lelièvre France

Beáta Flachner Hungary

Emilia Rappocciolo Italy

James K. Hogan

222 ×1.7

129 ×2.1

ONCOL

79 ×1.5

27 ×1.0

BIOTE

24 ×0.9

GENET

Citations per year, relative to James K. Hogan James K. Hogan (= 1×) peers Emilia Rappocciolo

Countries citing papers authored by James K. Hogan

Since Specialization

Citations

This map shows the geographic impact of James K. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James K. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James K. Hogan more than expected).

Fields of papers citing papers by James K. Hogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James K. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James K. Hogan. The network helps show where James K. Hogan may publish in the future.

Co-authorship network of co-authors of James K. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of James K. Hogan. A scholar is included among the top collaborators of James K. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James K. Hogan. James K. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Mahajan, Sudipta, James K. Hogan, Luke S. Oh, et al.. (2015). VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease. Journal of Pharmacology and Experimental Therapeutics. 353(2). 405–414. 49 indexed citations

Miller, Bailey W., Aaron J. Friedman, Hyukjae Choi, et al.. (2013). The Marine Cyanobacterial Metabolite Gallinamide A Is a Potent and Selective Inhibitor of Human Cathepsin L. Journal of Natural Products. 77(1). 92–99. 48 indexed citations

Wang, Tiansheng, Mark W. Ledeboer, John P. Duffy, et al.. (2010). ChemInform Abstract: A Novel Chemotype of Kinase Inhibitors: Discovery of 3,4‐Ring Fused 7‐Azaindoles and Deazapurines as Potent JAK2 Inhibitors.. ChemInform. 41(21). 1 indexed citations

Wang, Tiansheng, Mark W. Ledeboer, John P. Duffy, et al.. (2009). A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(1). 153–156. 40 indexed citations

Willis, Melissa Swope, James K. Hogan, Prakash Prabhakar, et al.. (2005). Investigation of protein refolding using a fractional factorial screen: A study of reagent effects and interactions. Protein Science. 14(7). 1818–1826. 61 indexed citations

Sakowicz, Roman, Valeri Martichonok, James K. Hogan, et al.. (1996). Probing Enzyme Specificity.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 50. 697–706. 4 indexed citations

Bonneau, Pierre, Richard Martin, Roman Sakowicz, et al.. (1996). Enzymes in Organics Synthesis. Present and Future. Journal of the Brazilian Chemical Society. 7(5). 357–369.

Hogan, James K., et al.. (1995). Improved specificity toward substrates with positively charged side chains by site-directed mutagenesis of the L-lactate dehydrogenase of Bacillus stearothermophilus. Biochemistry. 34(13). 4225–4230. 14 indexed citations

Kallwass, Helmut, James K. Hogan, Emma L. A. Macfarlane, et al.. (1992). On the factors controlling the structural specificity and stereospecificity of the L-lactate dehydrogenase from Bacillus stearothermophilus: effects of Gln102.fwdarw.Arg and Arg171.fwdarw.Trp/Tyr double mutations. Journal of the American Chemical Society. 114(27). 10704–10710. 31 indexed citations

10.

Ledinko, Nada, et al.. (1988). Inhibition of invasion activity in vitro by a novel class of antitumor agents: silatrane derivatives.. PubMed. 8(2). 249–53. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact